全文获取类型
收费全文 | 13311篇 |
免费 | 1012篇 |
国内免费 | 296篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 42篇 |
妇产科学 | 785篇 |
基础医学 | 1263篇 |
口腔科学 | 28篇 |
临床医学 | 896篇 |
内科学 | 1024篇 |
皮肤病学 | 141篇 |
神经病学 | 40篇 |
特种医学 | 305篇 |
外国民族医学 | 5篇 |
外科学 | 4870篇 |
综合类 | 1966篇 |
现状与发展 | 2篇 |
预防医学 | 652篇 |
眼科学 | 86篇 |
药学 | 736篇 |
6篇 | |
中国医学 | 230篇 |
肿瘤学 | 1525篇 |
出版年
2024年 | 20篇 |
2023年 | 133篇 |
2022年 | 242篇 |
2021年 | 378篇 |
2020年 | 400篇 |
2019年 | 384篇 |
2018年 | 401篇 |
2017年 | 430篇 |
2016年 | 446篇 |
2015年 | 433篇 |
2014年 | 860篇 |
2013年 | 826篇 |
2012年 | 812篇 |
2011年 | 994篇 |
2010年 | 849篇 |
2009年 | 774篇 |
2008年 | 801篇 |
2007年 | 849篇 |
2006年 | 730篇 |
2005年 | 593篇 |
2004年 | 470篇 |
2003年 | 417篇 |
2002年 | 379篇 |
2001年 | 309篇 |
2000年 | 194篇 |
1999年 | 167篇 |
1998年 | 210篇 |
1997年 | 173篇 |
1996年 | 145篇 |
1995年 | 113篇 |
1994年 | 93篇 |
1993年 | 74篇 |
1992年 | 53篇 |
1991年 | 50篇 |
1990年 | 30篇 |
1989年 | 34篇 |
1988年 | 41篇 |
1987年 | 41篇 |
1986年 | 32篇 |
1985年 | 49篇 |
1984年 | 39篇 |
1983年 | 27篇 |
1982年 | 34篇 |
1981年 | 34篇 |
1980年 | 31篇 |
1979年 | 10篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 6篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
N. E. Kushlinskii L. M. Gorilovskii V. D. Ermilova N. L. Svetozarskii B. V. Bukharkin V. G. Degtyar' 《Bulletin of experimental biology and medicine》1996,122(4):1028-1031
The occurrence and mean content of androgen receptors in the cytosolic fraction of prostatic adenocarcinoma depend on the
age of patients, stage of tumor anaplasia, tumor differentiation, type of therapy, and the concentration of androgen receptors.
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 122, No. 10, pp. 432–436, October, 1996 相似文献
93.
John T. Leith 《The Prostate》1994,24(3):119-124
Because there is extremely limited information on the intrinsic radiosensitivity of human prostatic cancer cells, we have investigated the in vitro radiation response of exponentially growing LNCaP cells. Due to the very poor colony-forming potential of the LNCaP cells, radiation survival was investigated using the dose-dependent (0-6 Gy) changes seen after X-irradiation in the shapes of regrowth curves. Survival was described using both the single-hit, multitarget (SHMT) equation and the linear-quadratic (LQ) equation. The values and 95% confidence limits of the extrapolation number (n), quasi-threshold dose (Dq), and mean lethal dose (Do) in SHMT terminology were respectively: 0.9 (0.7-1.0), 0.0 Gy, and 1.39 (0.11) Gy. The LQ alpha and beta parameters were respectively 6.80 (1.13) and -0.53 (2.89). The X-ray dose response of the LNCaP line is, therefore, purely exponential. The mean survival at the clinically relevant dose of 2 Gy (S2) was 51.2% for the LNCaP line. Comparison of the S2 value for the LNCaP line with previous investigations with other human prostatic cancer cell lines (DU145 and PC-3) indicates a mean S2 value of 47.6%, which suggests that human prostate cancer cells might lie toward the resistant side of the spectrum for various classes of human neoplasms. © 1994 Wiey-Liss, Inc. 相似文献
94.
J. Ignacio Herrero Juan Felipe Lucena Jorge Quiroga Bruno Sangro Fernando Pardo Fernando Rotellar Javier Alvárez-Cienfuegos Jesús Prieto 《American journal of transplantation》2003,3(11):1407-1412
Older age is not considered a contraindication for liver transplantation, but age-related morbidity may be a cause of mortality. Survival and the incidence of the main post-transplant complications were assessed in 111 adult liver transplant recipients. They were divided in two groups according to their age (patients younger than 60 years, n=54; patients older than 60 years, n=57) and both groups were compared. Older patients were more frequently transplanted for hepatitis C (p= 0.03) and hepatocellular carcinoma (p= 0.05) and their liver disease was less advanced (Child-Pugh and MELD scores were significantly lower; p=0.004 and p=0.05, respectively). After transplantation, older patients had a significantly lower survival (p=0.02). Higher age was independently associated with mortality (hazard ratio for each 10-year increase: 2.1; 95% confidence interval: 1.1- 4.0; p=0.02). The incidence of de novo neoplasia and nonskin neoplasia were higher in older patients (p=0.02 and p =0.007, respectively). Malignancy was the cause of death in one patient younger than 60 years and in 12 patients older than 60 years (p =0.002). In multivariate analysis, a higher age and smoking were independently associated with a higher risk of dying of de novo neoplasia. In conclusion, older liver transplant recipients have a significantly lower survival than younger patients. Malignancy is responsible for this decreased survival. 相似文献
95.
KAMIL CAM YAVUZ AKMAN ALI KAYIKCI FERDA SENEL ALI EROL 《International journal of urology》2003,10(11):582-586
BACKGROUND: The severity of symptoms still constitutes the major indication for transurethral prostatectomy, despite the extensive utilization of medical treatments. The aim of the study presented here was to investigate the impact of doxazosin on symptoms in relation to the probability of consequent surgery in severely symptomatic patients. METHODS: Patients with an International Prostate Symptom Score (IPSS) between 18 and 35 were included in the study. The patients received 4 mg/day doxazosin, and subjective efficacy was assessed by IPSS at the first and third months. In addition, the patients were classified at the third month according to a single question regarding satisfaction with medical treatment in terms of symptom relief as 'ineffective, no change, and effective'. RESULTS: A total of 178 patients constituted the study group. Mean total symptom scores were 24, 19 and 17 at baseline, first and third months, respectively (P < 0.05). According to results of the questionnaire, 23% of the patients claimed the treatment was ineffective, and subsequently, the majority of this group (93%) underwent prostatectomy in a year. In addition, 33% of the patients reported no change in their symptoms, while 44% reported that the medication was effective. However, after 1 year, 59% and 15% of these cases underwent surgical treatment, respectively. The probability of surgery in the 'ineffective' group was significantly higher compared to the remaining groups (P < 0.05). CONCLUSION: The majority of patients with severe symptoms who were not satisfied with the medication at the 3rd month underwent surgery. This observation may provide a predictor for subsequent probability of prostatectomy. Therefore, reassessment of patients would be a cost-effective approach for the treatment of BPH in severely symptomatic patients. 相似文献
96.
目的:探讨经尿道等离子前列腺双极汽化电切术(TUPKVP)治疗前列腺增生的效果。方法:回顾性分析580例良性前列腺增生(BPH)患者行TUPKVP的临床资料。结果:中转开放手术2例,切除前列腺组织10~80 g,平均32.5 g。手术时间25~150 min,平均60 min,术中输血10例,无电切综合征(TURS)发生。术后随访2~36个月,患者最大尿流率升高,IPSS症状评分值降低,排尿通畅,疗效好,并发症少。结论:TUPKVP出血少,手术安全,疗效确切,是治疗前列腺增生的有效方法。 相似文献
97.
目的:探讨经直肠彩色多普勒超声对良性前列腺增生的诊断价值。方法:采用经直肠彩色多普勒对37例良性前列腺增生患者进行检查,测量大小,计算体积,并按前列腺重量分成四组,测定、分析增生内腺动脉的血液动力学参数。分组评价增生内腺的彩色血流图。结果:随前列腺重量的增加,增生内腺血流分布逐渐增加,血流的最大流度(Vmax)、血流最低流速(Vmin)、血流阻力指数(RI)、搏动指数(PI)逐渐增加。结论:经直肠彩色多普勒检查有助于临床对前列腺增生的准确诊断。 相似文献
98.
应用免疫组化(ABC法)和银染技术检测10树前列腺癌和20例前列腺增生患者增殖细胞核抗原(PCNA)和核仁组成区嗜银蛋白(AgNOR)数量变化.结果显示PCNA阳性检出率及AgNOR计数有显著差异(P<0.01).且随肿瘤分级增高而增高.随访资料显示PCNA强级(~)者,AgNOR计数高者预后明显低于PCNA弱级(~),AgNOR计数低者.结果提示PCNA,AgNOR可作为前列腺良恶性肿瘤鉴别诊断指标之一,并且与前列腺癌恶性程度有关,对推测预后具有重要参考价值。 相似文献
99.
Three predominant proteins secreted by the human prostate gland 总被引:3,自引:0,他引:3
Analyses of the proteins of azoospermic ejaculates from subjects with defective seminal vesicles demonstrated that three prostatic-secreted proteins were predominant. Prostatic acid phosphatase (PAP), prostate-specific antigen (PSA; or gamma-seminoprotein), and beta-microseminoprotein (beta-MSP; or beta-inhibin), were identified as the three predominant proteins secreted by the normal human prostate gland. Immunohistochemical localization of these proteins, in the epithelium of normal prostatic acini and ducts, with the avidin-biotin complex procedure demonstrated that each PAP-immunoreactive cell was invariably immunoreactive both with PSA-and beta-MSP-monospecific antisera as well. 相似文献
100.